VACCINEX, INC. Annual Costs and Expenses in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Vaccinex, Inc. quarterly/annual Costs and Expenses history and growth rate from 2017 to 2023.
  • Vaccinex, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $4.6M, a 21.4% decline year-over-year.
  • Vaccinex, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $20.7M, a 13% decline year-over-year.
  • Vaccinex, Inc. annual Costs and Expenses for 2023 was $23.5M, a 16.2% increase from 2022.
  • Vaccinex, Inc. annual Costs and Expenses for 2022 was $20.2M, a 13.7% decline from 2021.
  • Vaccinex, Inc. annual Costs and Expenses for 2021 was $23.4M, a 19.2% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $23.5M +$3.27M +16.2% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-04-25
2022 $20.2M -$3.21M -13.7% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-04-25
2021 $23.4M -$5.57M -19.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $29M -$3.58M -11% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $32.5M +$4.53M +16.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $28M +$6.81M +32.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 $21.2M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.